HSBC Holdings
BOLD

HSBC Holdings’s Audentes Therapeutics, Inc BOLD Stock Holding History

HSBC Holdings’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-5,197
Closed -$312K – 3176
2019
Q4 		$312K Sell
5,197
-4,456
-46% -$167K ﹤0.01% 2519
2019
Q3 		$271K Buy
+9,653
New +$329K ﹤0.01% 2696

HSBC Holdings's BOLD Position: Q1 2020 in Review

HSBC Holdings sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 5,197 shares — an estimated $312K sold.

HSBC Holdings first reported a position in BOLD in Q3 2019 and held it in 2 quarters. The position peaked at $312K in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • HSBC Holdings reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • HSBC Holdings sold 5,197 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $312K.
  • HSBC Holdings first reported a position in Audentes Therapeutics, Inc in Q3 2019 and held it in 2 quarters.
  • HSBC Holdings's Audentes Therapeutics, Inc position peaked at $312K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on HSBC Holdings's 13F filing for Q1 2020, filed 15 May 2020.